Grufity logo
Grufity logo

Latest Privium Fund Management B.V. Stock Portfolio

$480Million | No. of Holdings #60

Privium Fund Management B.V. Performance

2026 Q1-13.90%
YTD-13.90%
2025+33.11%

About Privium Fund Management B.V. and 13F Hedge Fund Stock Holdings

On 2026-05-05, the fund reported it's updated stock portfolio. In the 13F Holdings report, Privium Fund Management B.V. reported an equity portfolio of $480.3 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of Privium Fund Management B.V. are TSLA, SHOP, SPOT. The fund has invested 17.2% of it's portfolio in TESLA INC and 10.1% of portfolio in SHOPIFY INC. <br><br> The fund managers got completely rid off MERCK & CO INC (MRK), VIZSLA SILVER CORP (VZLA) and VALARIS LTD (VAL) stocks. They significantly reduced their stock positions in SLB LIMITED (SLB), BIOGEN INC (BIIB) and MODERNA INC (MRNA). Privium Fund Management B.V. opened new stock positions in ESPERION THERAPEUTICS INC NE (ESPR), BIOMARIN PHARMACEUTICAL INC (BMRN) and DENALI THERAPEUTICS INC (DNLI). The fund showed a lot of confidence in some stocks as they added substantially to ROCKET PHARMACEUTICALS INC (RCKT), PFIZER INC (PFE) and VOYAGER THERAPEUTICS INC (VYGR).
Privium Fund Management B.V. Equity Portfolio Value
Last Reported on: 05 May, 2026
$480Million
  as of May 05, 2026

Privium Fund Management B.V. Annual Return Estimates Vs S&P 500

Our best estimate is that Privium Fund Management B.V. made a return of -13.9% in the last quarter. In trailing 12 months, it's portfolio return was 25.26%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
esperion therapeutics inc ne9,040,470
biomarin pharmaceutical inc5,214,310
denali therapeutics inc4,893,250
alnylam pharmaceuticals inc4,043,890
molina healthcare inc1,085,060
b2gold corp437,041
pan amern silver corp213,057
New stocks bought by Privium Fund Management B.V.

Additions

Ticker% Inc.
rocket pharmaceuticals inc42.32
pfizer inc39.55
voyager therapeutics inc26.32
wave life sciences ltd24.87
vertex pharmaceuticals inc21.38
ionis pharmaceuticals inc20.43
uniqure nv16.88
iren limited14.34
Additions to existing portfolio by Privium Fund Management B.V.

Reductions

Ticker% Reduced
slb limited-52.45
biogen inc-40.39
moderna inc-39.52
sprott fds tr-38.93
noble corp plc-36.87
transocean ltd-23.64
nov inc-20.89
4d molecular therapeutics in-18.93
Privium Fund Management B.V. reduced stake in above stock

Sold off

Ticker$ Sold
vizsla silver corp-1,119,460
merck & co inc-3,851,780
nomad foods ltd-102,569
valaris ltd-318,276
Privium Fund Management B.V. got rid off the above stocks

Sector Distribution

Privium Fund Management B.V. has about 30.5% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
  • Consumer Cyclical
  • Technology
  • Financial Services
Sector%
Healthcare30.5
Others25.6
Consumer Cyclical22.6
Technology14.2
Financial Services6.2

Market Cap. Distribution

Privium Fund Management B.V. has about 50.2% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MEGA-CAP
  • UNALLOCATED
  • MID-CAP
  • LARGE-CAP
  • SMALL-CAP
Category%
MEGA-CAP34.3
UNALLOCATED25.6
MID-CAP16
LARGE-CAP15.9
SMALL-CAP7.8

Stocks belong to which Index?

About 51.9% of the stocks held by Privium Fund Management B.V. either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • S&P 500
  • RUSSELL 2000
Index%
Others48.1
S&P 50031.9
RUSSELL 200020
Top 5 Winners (%)%
TDW
tidewater inc new
65.4 %
noble corp plc
60.2 %
MRNA
moderna inc
58.0 %
RIG
transocean ltd
53.4 %
SLB
slb limited
25.0 %
Top 5 Winners ($)$
ASTS
ast spacemobile inc
1.5 M
MRNA
moderna inc
0.8 M
ABEV
ambev sa
0.5 M
BIIB
biogen inc
0.4 M
SLB
slb limited
0.4 M
Top 5 Losers (%)%
WVE
wave life sciences ltd
-54.8 %
lexeo therapeutics inc
-41.5 %
VRDN
viridian therapeutics inc
-37.1 %
HIMS
hims & hers health inc
-36.1 %
SE
sea ltd
-35.1 %
Top 5 Losers ($)$
TSLA
tesla inc
-17.6 M
SHOP
shopify inc
-17.3 M
SPOT
spotify technology s a
-6.5 M
PLTR
palantir technologies inc
-6.3 M
SE
sea ltd
-6.2 M

Privium Fund Management B.V. Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Privium Fund Management B.V.

Privium Fund Management B.V. has 60 stocks in it's portfolio. About 64% of the portfolio is in top 10 stocks. TSLA proved to be the most loss making stock for the portfolio. ASTS was the most profitable stock for Privium Fund Management B.V. last quarter.

$480.31MTotal Value
64.00Positions
05 May, 2026Last Reported
Current holdings of Current Stock Holdings of Privium Fund Management B.V., last reported on 05 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ABEV
Ambev Sa

Ambev Sa

ABEV
Privium Fund Management B.V.'s holding in Ambev Sa over time
0.58%948,558
$2.77M
0.58%
decreased 10.78 percentreduced
AUTL
Autolus Therapeutics Ltd

Autolus Therapeutics Ltd

AUTL
Privium Fund Management B.V.'s holding in Autolus Therapeutics Ltd over time
0.1%363,430
$501.5K
0.1%
increased 11.4 percentadded
BNTX
Biontech Se

Biontech Se

BNTX
Privium Fund Management B.V.'s holding in Biontech Se over time
0.5%27,000
$2.40M
0.5%
decreased 18.92 percentreduced
BTG
B2gold Corp

B2gold Corp

BTG
Privium Fund Management B.V.'s holding in B2gold Corp over time
0.09%96,477
$437.0K
0.09%
new position